Psychometric analysis of the adult sickle cell quality of life measurement information system (ACSQ-Me) in a UK population

• Main Authors: Owen Cooper, Hayley McBain, Sekayi Tangayi, Paul Telfer, Dimitris Tsitsikas, Anne Yardumian, Kathleen Mulligan
• Format: Article
• Language: English
• Published: BMC 2019-04-01
• Series: Health and Quality of Life Outcomes
• Subjects: Sickle cell disease; Quality of life; ASCQ-Me; SF-36; Validity
• Online Access: http://link.springer.com/article/10.1186/s12955-019-1136-7

Abstract Background The Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me) has been shown to be a reliable and valid questionnaire measuring health-related quality of life (HRQoL) in the US sickle cell disease (SCD) population. The study objective was to test the validity and reliability of the ASCQ-Me for use in the UK. Methods The US ASCQ-Me, Hospital Anxiety and Depression Scale (HADS), self-reported symptoms, and Medical Outcome Survey Short Form 36 (SF-36) were administered to 173 patients with SCD. Clinical severity was assessed by the number of painful episodes indicated by hospital admissions. Results The results showed that the item banks of the UK ASCQ-Me had good internal consistency. Anxiety and depression were strongly correlated with the emotional, and social item banks of the UK ASCQ-Me, with moderate correlations between the UK ASCQ-Me item banks and SF-36 components suggesting convergent validity. A confirmatory factor analysis confirmed the conceptual framework of the scale as being the same as the US ASCQ-Me, indicating construct validity. Known groups validity was found, with the ASCQ-Me being able to differentiate by SCD severity groups. Conclusion The analysis of the sample shows evidence of both validity and reliability of the ASCQ-Me for use in the UK SCD population.